The continuing medical education (CME) field is always changing. That’s a good thing, because it means we are keeping up with the rapid changes in the medical field, accommodating the needs of our learners, and discovering newer and better ways …
A recent Harris Poll survey about attitudes toward mental health was conducted on behalf of the Anxiety and Depression Associations of America, American Foundation for Suicide Prevention and the National Alliance for Suicide Prevention. Over 2,000 US adults over 18 …
New to the diagnosis of major depressive disorder as of DSM-5 is the specifier “with mixed features.” According to DSM-5, “specifiers provide an opportunity to define a more homogeneous subgrouping of individuals with the disorder who share certain features (e.g., …
Why CME Providers Are Celebrating This Week: Decades Worth of CME Studies Found That CME Is Undeniably An Effective Learning Hub For Physicians By: Haley Hoffman and Beth Brillinger, CCMEP
Last week, the Accreditation Council for Continuing Medical Education (ACCME) …
Researchers from UC San Francisco have completed the first Internet-based clinical trial for children with autism, establishing it as a viable and cost effective method of conducting high-quality and rapid clinical trials in this population.[More…]…
Promises are social contracts that can be broken, kept, or exceeded. Breaking one’s promise is evaluated more negatively than keeping one’s promise. Does expending more effort to exceed a promise lead to equivalently more positive evaluations?
Although linear in their …
A meta-analysis of clinical trial data published this week in JAMA Internal Medicine suggests that risk for suicidal behavior is twice as likely when children and young adults who are diagnosed with depression are given antidepressants compared to placebo. A …
The Food and Drug Administration yesterday announced changes to the labeling requirements for long-acting pain medication. In addition, FDA has ordered new postmarket study requirements for all extended-release and long-acting (ER/LA) opioid analgesics intended to treat pain.
The modified indication, …
